rs2236142
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000416671.5(CHEK2):n.-194C>G variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.638 in 846,056 control chromosomes in the GnomAD database, including 176,623 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.66 ( 33322 hom., cov: 32)
Exomes 𝑓: 0.63 ( 143301 hom. )
Consequence
CHEK2
ENST00000416671.5 5_prime_UTR_premature_start_codon_gain
ENST00000416671.5 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.264
Publications
25 publications found
Genes affected
CHEK2 (HGNC:16627): (checkpoint kinase 2) In response to DNA damage and replication blocks, cell cycle progression is halted through the control of critical cell cycle regulators. The protein encoded by this gene is a cell cycle checkpoint regulator and putative tumor suppressor. It contains a forkhead-associated protein interaction domain essential for activation in response to DNA damage and is rapidly phosphorylated in response to replication blocks and DNA damage. When activated, the encoded protein is known to inhibit CDC25C phosphatase, preventing entry into mitosis, and has been shown to stabilize the tumor suppressor protein p53, leading to cell cycle arrest in G1. In addition, this protein interacts with and phosphorylates BRCA1, allowing BRCA1 to restore survival after DNA damage. Mutations in this gene have been linked with Li-Fraumeni syndrome, a highly penetrant familial cancer phenotype usually associated with inherited mutations in TP53. Also, mutations in this gene are thought to confer a predisposition to sarcomas, breast cancer, and brain tumors. This nuclear protein is a member of the CDS1 subfamily of serine/threonine protein kinases. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
HSCB (HGNC:28913): (HscB mitochondrial iron-sulfur cluster cochaperone) This gene encodes a DnaJ-type co-chaperone and member of the heat shock cognate B (HscB) family of proteins. The encoded protein plays a role in the synthesis of iron-sulfur clusters, protein cofactors that are involved in the redox reactions of mitochondrial electron transport and other processes. Cells in which this gene is knocked down exhibit reduced activity of iron-sulfur cluster-dependent enzymes including succinate dehydrogenase and aconitase. The encoded protein may stimulate the ATPase activity of the mitochondrial stress-70 protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
HSCB Gene-Disease associations (from GenCC):
- anemia, sideroblastic, 5Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.72).
BP6
Variant 22-28741956-G-C is Benign according to our data. Variant chr22-28741956-G-C is described in ClinVar as Benign. ClinVar VariationId is 1268378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.704 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CHEK2 | NM_007194.4 | c.-194C>G | upstream_gene_variant | ENST00000404276.6 | NP_009125.1 | |||
| HSCB | NM_172002.5 | c.-140G>C | upstream_gene_variant | ENST00000216027.8 | NP_741999.3 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.656 AC: 99757AN: 151974Hom.: 33304 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
99757
AN:
151974
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.633 AC: 439625AN: 693964Hom.: 143301 Cov.: 9 AF XY: 0.625 AC XY: 222022AN XY: 355154 show subpopulations
GnomAD4 exome
AF:
AC:
439625
AN:
693964
Hom.:
Cov.:
9
AF XY:
AC XY:
222022
AN XY:
355154
show subpopulations
African (AFR)
AF:
AC:
12354
AN:
17270
American (AMR)
AF:
AC:
12728
AN:
22574
Ashkenazi Jewish (ASJ)
AF:
AC:
7737
AN:
15874
East Asian (EAS)
AF:
AC:
11459
AN:
32278
South Asian (SAS)
AF:
AC:
23192
AN:
53068
European-Finnish (FIN)
AF:
AC:
20563
AN:
30026
Middle Eastern (MID)
AF:
AC:
1881
AN:
3934
European-Non Finnish (NFE)
AF:
AC:
328803
AN:
484876
Other (OTH)
AF:
AC:
20908
AN:
34064
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
8285
16570
24854
33139
41424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
5672
11344
17016
22688
28360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.656 AC: 99819AN: 152092Hom.: 33322 Cov.: 32 AF XY: 0.651 AC XY: 48419AN XY: 74360 show subpopulations
GnomAD4 genome
AF:
AC:
99819
AN:
152092
Hom.:
Cov.:
32
AF XY:
AC XY:
48419
AN XY:
74360
show subpopulations
African (AFR)
AF:
AC:
29505
AN:
41488
American (AMR)
AF:
AC:
9275
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1721
AN:
3472
East Asian (EAS)
AF:
AC:
1924
AN:
5150
South Asian (SAS)
AF:
AC:
2041
AN:
4820
European-Finnish (FIN)
AF:
AC:
7274
AN:
10580
Middle Eastern (MID)
AF:
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
AC:
46056
AN:
67992
Other (OTH)
AF:
AC:
1237
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1777
3554
5332
7109
8886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
786
1572
2358
3144
3930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1339
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 22, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.